Document is current
Any future updates will be listed below
-
Authors
Malli Cetinbas, Naniye https://orcid.org/0000-0003-2798-4620
Monnell, Travis
Soomer-James, Jahna
Shaw, Pamela https://orcid.org/0009-0008-3966-7300
Lancaster, Kelly
Catcott, Kalli C. https://orcid.org/0000-0003-1941-0678
Dolan, Melissa
Mosher, Rebecca
Routhier, Caitlin https://orcid.org/0009-0001-0727-0842
Chin, Chen-Ni
Toader, Dorin
Duvall, Jeremy
Bukhalid, Raghida
Lowinger, Timothy B. https://orcid.org/0000-0002-4209-3693
Damelin, Marc https://orcid.org/0000-0003-0512-7126
- License Information
-
More Information
Article History
Received: 11 May 2023
Accepted: 25 June 2024
First Online: 11 July 2024
Competing interests
: All authors are current or former employees of Mersana Therapeutics and may hold stock options and/or equity in Mersana Therapeutics Inc. Related patents: US11,155,567: Sting agonist compounds and methods of use, WO2021/202984: Antibody-drug conjugates comprising sting agonizts.
